XML 52 R42.htm IDEA: XBRL DOCUMENT v3.21.1
License and Collaboration Agreements - Additional Information (Details) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Sep. 30, 2020
Mar. 31, 2021
Sep. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Research and License Agreements          
Revenue   $ 1,055,441   $ 9,000,000  
Apollomics, Inc.          
Research and License Agreements          
Up-front payment received         $ 9,000,000.0
Milestones based on achievement of certain clinical and regulatory events         75,000,000.0
Milestone payment upon achievement of specified net sales thresholds for all licensed products         $ 105,000,000.0
Milestone revenue recognized based on achievement of certain clinical and regulatory events $ 1,000,000.0   $ 1,000,000.0    
Revenue   $ 1,100,000      
Apollomics, Inc. | Maximum          
Research and License Agreements          
Tiered percentage of annual net sales         15.00%